<DOC>
	<DOCNO>NCT03021577</DOCNO>
	<brief_summary>The investigator hypothesize orbital atherectomy system ( OAS ) , new generation atherectomy device , reduce incidence microcirculatory compromise compare old generation rotational atherectomy ( RA ) due difference mechanism athero-ablation .</brief_summary>
	<brief_title>Comparison Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation PCI</brief_title>
	<detailed_description>The presence heavily calcify coronary lesion necessitates use ablative device aid successful percutaneous coronary intervention ( PCI ) . However , atherectomy device generate microparticles embolize distal coronary microcirculation may compromise myocardial tissue perfusion . Two mechanism deserve particular attention eccentric mount OAS crown high flow rate vasodilator flush . Firstly , oppose rotational atherectomy large , centrally mount burr may cause obstruction flow atherectomy , small eccentrically mount crown OAS allow continuous perfusion atherectomy well rest period . Second , rest atherectomy , flow rate vasodilatory flush high OAS compare RA . Combined , difference coronary vasodilator flush flow could lead improved perfusion distal circulation , particularly atherectomy run risk embolization high . The loss microcirculatory function transient , partial complete restoration microcirculatory blood flow , permanent . As show study patient acute coronary syndrome , loss microcirculatory function critical independent predictor myocardial recovery adverse outcome . The putative protective effect OAS coronary microvasculature may therefore major clinical significance impact .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Patient indication PCI include : Angina ( stable unstable ) , Silent ischemia ( visually estimate target lesion diameter stenosis ≥70 % , positive noninvasive stress test , FFR ≤0.80 must present ) , NonST Segment Elevation Myocardial Infarction ( NSTEMI ) 3 . Patients undergo cardiac catheterization possible definite PCI intent stent use noninvestigational metallic drugeluting stent ( DES ) 4 . Signed write informed consent 5 . Heavily calcify ( severe ) lesion necessitate atherectomy . Angiographic inclusion criterion : 1 . The target lesion must locate native coronary artery visually estimate reference vessel diameter ≥2.25 mm ≤4.00 mm . 2 . Lesion length 20 mm 50mm 1 . Estimated creatinine clearance &lt; 30 ml/min use CockcroftGault equation , unless patient dialysis ; 2 . STelevation Myocardial Infarction ( STEMI ) within 24 hour initial time presentation first treat hospital , whether transfer facility study hospital . 3 . PCI within 24 hour precede study procedure . 4 . Cardiogenic shock ( defined persistent hypotension ( systolic blood pressure &lt; 90 mm/Hg 30 minute ) require pressor hemodynamic support , include intraaortic balloon pump ( IABP ) , time procedure . 5 . Mobitz II second degree complete heart block 6 . Malignant ventricular arrhythmia require treatment 7 . Pulmonary edema define patient shortness breath , evidence volume overload physical exam , crepitation physical exam ( &gt; 1/3 lung ) radiographic interstitial alveolar pulmonary edema 8 . Subject intubate . 9 . Known leave ventricular ejection fraction ( LVEF ) &lt; 35 % . 10 . Severe valvular disease ( e.g . severe mitral regurgitation severe aortic stenosis ) 11 . Patient participate investigational drug device clinical trial reach primary endpoint . 12 . Women pregnant breastfeeding ( woman childbearing potential must negative pregnancy test within one week treatment ) . General Inclusion MRI SubStudy 1 . Patients prior MI/scarring subtend myocardial territory . 2 . Patients contraindication MRI study 3 . Patients could safely receive Gadolinium ( i.e . estimate glomerular filtration rate ( eGFR ) &gt; 30 ) Angiographic 1 . Lesion length &lt; 20mm 2 . Study target lesion bypass graft 3 . Ostial right coronary artery ( RCA ) study target lesion 4 . Chronic total occlusion ( Thrombolysis In Myocardial Infarction ( TIMI ) flow 0/1 ) study target lesion 5 . Bifurcation study lesion plan dual stent strategy 6 . Instent restenosis study target lesion General Inclusion MRI SubStudy 1 . Patients prior myocardial infarction ( MI ) /scarring subtend myocardial territory . 2 . Patients contraindication Magnetic resonance imaging ( MRI ) study 3 . Patients could safely receive Gadolinium ( i.e . eGFR &gt; 30 )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>orbital atherectomy system</keyword>
	<keyword>rotational atherectomy</keyword>
	<keyword>Fractional flow reserve</keyword>
	<keyword>coronary flow reserve</keyword>
	<keyword>index microcirculatory resistance ( IMR )</keyword>
</DOC>